|
http://www.aarkstore.com/reports/RCP-Diagnostics-LLC-Product-Pipeline-Analysis-164255.html Summary RCP Diagnostics, LLC is an in-vitro diagnostic company, engaged in marketing a blood test, RCP-Dx Test for cancers in women. The RCP-Dx Test is used to screen cancers such as ovarian, breast, cervical and uterine cancers from a single blood sample. The company plans to launch the RCP-Dx Test in to the market as early as possible to positively impact women’s survival rates from these deadly diseases. On December 7, 2006, GW Medical Technologies, Biomarker Technologies and RCP Diagnostics merged with Provista Life Sciences. This report is a source for data, analysis and actionable intelligence on the RCP Diagnostics, LLC portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. For more information, please visit: http://www.aarkstore.com/reports/RCP-Diagnostics-LLC-Product-Pipeline-Analysis-164255.html Or email us at contact@aarkstore.com or call +918149852585 Aarkstore Enterprise Tel : +912227453309 Mobile No:+08149852585 Email : contact@aarkstore.com Website : http://www.aarkstore.com Blog: http://www.emarketreports.com Follow us on twitter: http://twitter.com/aarkstoredotcom http://in.linkedin.com/in/aarkstore http://www.facebook.com/aarkstoreenterprise
Related Articles -
RCP, Diagnostics, LLC, Product, Pipeline, Analysis, Market, Research, Report, Business, Industry, Information, Automotive, Banking, Finance, Food, Beverages,
|
